SKI Market

Indian Indices

Nifty

24,379.60 -81.55
(-0.33%)

Sensex

80,641.07 -155.77
( -0.19%)

Bank Nifty

54,271.40 -648.10
( -1.18%)

Nifty IT

35,869.20 -122.05
( -0.34%)

Global Indices

Nasdaq

41,230.34 -108.09
(-0.26%)

Dow Jones

5,669.98 -37.69
(-0.66%)

Hang Seng

36,831.70 379.40
(1.04%)

Nikkei 225

8,596.35 99.55
(1.17%)

Forex

USD-INR

84.57 -0.05
(-0.06%)

EUR-INR

95.56 -0.09
(-0.09%)

GBP-INR

112.19 -0.34
(-0.31%)

JPY-INR

0.58 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zenith Health Care Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530665

INE812B01026

1.4118982

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.65

EPS(TTM)

Face Value()

Div & Yield %

Back

Envair Electrodyne reports standalone net profit of Rs 0.24 crore in the September 2024 quarter

Nov 13,2024

Net profit of Envair Electrodyne reported to Rs 0.24 crore in the quarter ended September 2024 as against net loss of Rs 0.09 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.31 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	0	0.31	-100
OPM %	0	-35.48	-
PBDT	0.24	-0.10	LP
PBT	0.24	-0.10	LP
NP	0.24	-0.09	LP

24,379.60 -81.55 (-0.33%)

80,641.07 -155.77 ( -0.19%)

54,271.40 -648.10 ( -1.18%)

35,869.20 -122.05 ( -0.34%)

41,230.34 -108.09 (-0.26%)

5,669.98 -37.69 (-0.66%)

36,831.70 379.40 (1.04%)

8,596.35 99.55 (1.17%)

84.57 -0.05 (-0.06%)

95.56 -0.09 (-0.09%)

112.19 -0.34 (-0.31%)

0.58 0.00 (-0.31%)